Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Castle

Showing results (381-390 of 507) with videos related to

Pageof 51
Sort By:
Schizophrenia (Heidelberg, Germany)|February 25, 2022
Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophreniaKarolina Kozak Bidzinski, Darby J E Lowe, Marcos Sanches, et al.
Drug and Alcohol Dependence|October 30, 2021
Relation of substance use disorders to mortality, accident and emergency department attendances, and hospital admissions: A 13-year population-based cohort study in Hong KongYue Wei, Jiaxi Zhao, Ian Ck Wong, et al.
Bjpsych Open|December 15, 2025
Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyNicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, et al.
The Australian and New Zealand Journal of Psychiatry|December 13, 2019
Meta-analysis of randomised controlled trials with <i>N</i>-acetylcysteine in the treatment of schizophreniaCaitlin Ob Yolland, Donal Hanratty, Erica Neill, et al.
Science Translational Medicine|June 24, 2011
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkeyLuk H Vandenberghe, Peter Bell, Albert M Maguire, et al.
BMC Psychiatry|September 16, 2016
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptomsSusan L Rossell, Paul S Francis, Cherrie Galletly, et al.
JAMA Network Open|July 28, 2022
Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With SchizophreniaYue Wei, Vincent K C Yan, Wei Kang, et al.
The Australian and New Zealand Journal of Psychiatry|May 15, 2020
Effectiveness of embedding a specialist preventive care clinician in a community mental health service in increasing preventive care provision: A randomised controlled trialCaitlin Mc Fehily, Kate M Bartlem, John H Wiggers, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 23, 2006
Microarray-based compendium of hepatic gene expression profiles for prototypical ADME gene-inducing compounds in rats and mice in vivoJ G Slatter, O Cheng, P D Cornwell, et al.
Trials|September 11, 2016
The Stroke and Carer Optimal Health Program (SCOHP) to enhance psychosocial health: study protocol for a randomized controlled trialCatherine Brasier, Chantal F Ski, David R Thompson, et al.
Pageof 51

Showing results (381-390 of 507) with videos related to

Sort By:
Pageof 51
Schizophrenia (Heidelberg, Germany)|February 25, 2022
Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophreniaKarolina Kozak Bidzinski, Darby J E Lowe, Marcos Sanches, et al.
Drug and Alcohol Dependence|October 30, 2021
Relation of substance use disorders to mortality, accident and emergency department attendances, and hospital admissions: A 13-year population-based cohort study in Hong KongYue Wei, Jiaxi Zhao, Ian Ck Wong, et al.
Bjpsych Open|December 15, 2025
Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyNicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, et al.
The Australian and New Zealand Journal of Psychiatry|December 13, 2019
Meta-analysis of randomised controlled trials with <i>N</i>-acetylcysteine in the treatment of schizophreniaCaitlin Ob Yolland, Donal Hanratty, Erica Neill, et al.
Science Translational Medicine|June 24, 2011
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkeyLuk H Vandenberghe, Peter Bell, Albert M Maguire, et al.
BMC Psychiatry|September 16, 2016
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptomsSusan L Rossell, Paul S Francis, Cherrie Galletly, et al.
JAMA Network Open|July 28, 2022
Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With SchizophreniaYue Wei, Vincent K C Yan, Wei Kang, et al.
The Australian and New Zealand Journal of Psychiatry|May 15, 2020
Effectiveness of embedding a specialist preventive care clinician in a community mental health service in increasing preventive care provision: A randomised controlled trialCaitlin Mc Fehily, Kate M Bartlem, John H Wiggers, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 23, 2006
Microarray-based compendium of hepatic gene expression profiles for prototypical ADME gene-inducing compounds in rats and mice in vivoJ G Slatter, O Cheng, P D Cornwell, et al.
Trials|September 11, 2016
The Stroke and Carer Optimal Health Program (SCOHP) to enhance psychosocial health: study protocol for a randomized controlled trialCatherine Brasier, Chantal F Ski, David R Thompson, et al.
Pageof 51